ATLAS / Macro Radar / Reporting / TYRA

Tyra Biosciences, Inc. (TYRA) reporting calendar

Tyra Biosciences, Inc. files periodic reports with the SEC as TYRA on Nasdaq. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
15 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
13 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open TYRA market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202613 May 202643 days0001193125-26-220645
10-K31 Dec 20252 Mar 202661 days0001193125-26-085490
10-Q30 Sep 20255 Nov 202536 days0001193125-25-266967
10-Q30 Jun 202514 Aug 202545 days0000950170-25-108899
10-Q31 Mar 20258 May 202538 days0000950170-25-066942
10-K31 Dec 202427 Mar 202586 days0000950170-25-046124
10-Q30 Sep 20247 Nov 202438 days0000950170-24-123346
10-Q30 Jun 20247 Aug 202438 days0000950170-24-092778
10-Q31 Mar 20249 May 202439 days0000950170-24-056971
10-K31 Dec 202319 Mar 202479 days0000950170-24-033461
10-Q30 Sep 20237 Nov 202338 days0000950170-23-060276
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041382
10-Q31 Mar 20234 May 202334 days0000950170-23-017875
10-K31 Dec 202222 Mar 202381 days0000950170-23-009181
10-Q30 Sep 20223 Nov 202234 days0000950170-22-021937
10-Q30 Jun 20224 Aug 202235 days0000950170-22-014802
10-Q31 Mar 20225 May 202235 days0000950170-22-007879
10-K31 Dec 20213 Mar 202262 days0000950170-22-002814
10-Q30 Sep 20213 Nov 202134 days0000950170-21-002837

Source: SEC EDGAR company submissions for CIK 0001863127. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.